Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 5 studies | 45% ± 28% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 45% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 74% | 3411.26 | 1950 / 2642 | 43% | 4.27 | 301 / 705 |
intestine | 49% | 639.28 | 478 / 966 | 57% | 1.98 | 300 / 527 |
blood vessel | 48% | 106.71 | 639 / 1335 | 0% | 0 | 0 / 0 |
stomach | 0% | 0 | 0 / 359 | 43% | 1.21 | 122 / 286 |
esophagus | 0% | 0.28 | 3 / 1445 | 17% | 0.52 | 31 / 183 |
bladder | 0% | 0 | 0 / 21 | 16% | 0.52 | 79 / 504 |
lung | 5% | 6.56 | 27 / 578 | 4% | 0.10 | 47 / 1155 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.08 | 2 / 29 |
pancreas | 0% | 0.28 | 1 / 328 | 6% | 0.20 | 10 / 178 |
ovary | 5% | 7.02 | 9 / 180 | 0% | 0.00 | 1 / 430 |
breast | 3% | 6.69 | 13 / 459 | 1% | 0.02 | 15 / 1118 |
uterus | 1% | 2.04 | 2 / 170 | 3% | 0.06 | 12 / 459 |
adipose | 3% | 4.21 | 40 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 3% | 0.07 | 13 / 406 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.04 | 1 / 45 |
adrenal gland | 0% | 6.66 | 1 / 258 | 1% | 0.06 | 3 / 230 |
heart | 1% | 1.57 | 9 / 861 | 0% | 0 | 0 / 0 |
prostate | 1% | 1.34 | 2 / 245 | 0% | 0 | 0 / 502 |
thymus | 1% | 0.79 | 4 / 653 | 0% | 0.00 | 1 / 605 |
skin | 0% | 0.20 | 3 / 1809 | 0% | 0.00 | 1 / 472 |
muscle | 0% | 0.24 | 2 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.26 | 2 / 929 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.01 | 1 / 901 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015824 | Biological process | proline transport |
GO_0089718 | Biological process | amino acid import across plasma membrane |
GO_0035524 | Biological process | proline transmembrane transport |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0030163 | Biological process | protein catabolic process |
GO_0006836 | Biological process | neurotransmitter transport |
GO_0097060 | Cellular component | synaptic membrane |
GO_0045202 | Cellular component | synapse |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0015193 | Molecular function | L-proline transmembrane transporter activity |
GO_0005298 | Molecular function | proline:sodium symporter activity |
Gene name | SLC6A7 |
Protein name | Transporter Sodium-dependent proline transporter (Solute carrier family 6 member 7) |
Synonyms | PROT |
Description | FUNCTION: Brain specific sodium (and chloride)-dependent proline transporter . Terminates the action of proline by its high affinity sodium-dependent reuptake into presynaptic terminals (Probable). . |
Accessions | ENST00000524041.1 Q99884 ENST00000230671.7 E5RJL1 |